Herpesvirus 8 (HHV‑8) DNA, Quantitative Real‑Time PCR
Also known as: HHV-8, Human Herpes Virus 8 (HHV-8), Kaposi's Sarcoma
Use
Human herpesvirus‑8 (HHV‑8) is associated with the development of all forms of Kaposi’s sarcoma, as well as some other rare lymphoproliferative diseases, such as primary effusion lymphoma and multicentric Castleman’s disease. Quantitative PCR may be used to monitor the level of viremia in a patient, often in the context of therapy.
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
Unknown biomarker
Other
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
1 mL (0.5 mL minimum)
Minimum Volume
0.5 mL
Container
EDTA (lavender‑top) or ACD (yellow‑top) tube
Storage Instructions
Room temperature: 48 hours; Refrigerated: 7 days; Frozen: 30 days
Causes for Rejection
Plasma collected in PPT (white‑top) tube is no longer accepted
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant